Trademark Overview
On Friday, June 21, 2024, a trademark application was filed for GENE THERAPY. REDEFINED. with the United States Patent and Trademark Office. The USPTO has given the GENE THERAPY. REDEFINED. trademark a serial number of 98612779. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, January 16, 2025. This trademark is owned by Kriya Therapeutics, Inc.. The GENE THERAPY. REDEFINED. trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Pharmaceutical Products categories with the following description:
Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing
Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune-system-related diseases and disorders
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders